Ambuz Bhatia

About Ambuz Bhatia

I am a results-driven Senior Scientist (R&D) at Biocon Biologics, passionate about bridging science, analytics, and strategy to accelerate the development of novel biologics and biosimilars.With hands-on experience in in-vitro bioassay development, surface plasmon resonance (SPR)–based kinetic analysis, and biostatistical data interpretation, I’ve contributed directly to the analytical similarity and regulatory success of Yesintek® (Ustekinumab biosimilar) — approved by the U.S. FDA (2024) and European Commission (2025).Beyond the lab, I specialize in data analytics (R, Excel), scientific writing, and regulatory documentation, enabling data-driven decision-making and cross-functional collaboration across R&D, manufacturing, and regulatory teams.Currently pursuing a Global MBA (IIM Kozhikode & University of Western Australia, expected March 2027), I’m expanding my expertise into strategic management, business analytics, and global healthcare consulting.My professional goal is to leverage my combined background in pharmacology, bioassay development, and business leadership to drive innovation at the intersection of biopharma research, data analytics, and healthcare strategy.

Experience

1. Senior Scientist

   Biocon Biologics

   Jul 2022 — Present · Bengaluru, IN

Education

• RAYAT BAHRA UNIVERSITY

  Bachelor of Pharmacy, Pharmacy

  2016 — 2020

• National Institute of Pharmaceutical Education and Research (NIPER) ,SAS NAGAR , Mohali

  Master of Science - MS, Pharmacology and Toxicology

• The University of Western Australia

  Global MBA, Business Administration and Management

• Indian Institute of Management, Kozhikode

  Global MBA, Business Administration and Management